Cerebrospinal Fluid Leakage
6
2
2
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
16.7%
1 terminated out of 6 trials
75.0%
-11.6% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (6)
Dural Medical Adhesive for Watertight Sealing in Dural Repair
Role of Novel RADA16 Hydrogel in Endoscopic Skull Base Surgery
Study to Evaluate the Effectivity and Safety of BIOSCAFF®H Compared to DuraGen®, in Patients Undergoing Dural Repair
Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage
Cerebrospinal Fluid Rhinorrhea After Functional Endoscopic Sinus Surgery
Performance and Safety of I-020805 in Prevention of Cerebrospinal Fluid (CSF) Leakage Following Elective Craniotomy